Señales en vivo de FENC | Maximiza tus Ganancias con Getagraph.com

VENDER 117329 min ago

@ $9.99

Emitido: 14 feb 2024 @ 09:33

Retorno: -7.61%

Señal anterior: feb 13 - 09:38

Señal anterior: Comprar

Retorno: -0.10 %

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 16:00):

Stats
Volumen de hoy	71 279.00
Volumen promedio	136 767
Capitalización de mercado	250.13M
EPS	$0 ( 2024-03-21 )
Próxima fecha de ganancias	( $-0.0400 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.38
ATR14	$0.0260 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Andrade Robert	Buy	1 042	Common shares
2024-04-30	Raykov Rosty	Buy	2 431	Common shares
2024-05-01	Raykov Rosty	Sell	2 431	Common shares
2024-04-18	Haigh Adrian	Buy	22 222	Common Shares
2024-04-17	Haigh Adrian	Buy	22 222	Common Shares

INSIDER POWER
8.47
Last 100 transactions
Buy: 1 356 995 \| Sell: 926 579

Volumen Correlación

Largo: 0.03 (neutral)

Corto: -0.96 (very strong negative)

Signal:(34.82) Neutral

Fennec Pharmaceuticals Correlación

10 Correlaciones Más Positivas
JD	0.927
NAKD	0.916
GBNH	0.912
WLTW	0.907
SIRI	0.906
LSXMA	0.906
LSXMK	0.906
DTSS	0.905
ALXO	0.904
GOOD	0.903

10 Correlaciones Más Negativas
PAE	-0.924
GPACU	-0.915
CMLF	-0.909
LMNR	-0.909
PUCKU	-0.905
RAM	-0.905
GXII	-0.904
SGEN	-0.902
CSLMU	-0.9
EBSB	-0.896

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Fennec Pharmaceuticals Correlación - Moneda/Commodity

-0.23
( neutral )

-0.69
( moderate negative )

0.00
( neutral )

0.90
( strong )

0.63
( weak )

Fennec Pharmaceuticals Finanzas

Annual	2023
Ingresos:	$21.64M
Beneficio Bruto:	$20.36M (94.08 %)
EPS:	$-0.610

FY	2023
Ingresos:	$21.64M
Beneficio Bruto:	$20.36M (94.08 %)
EPS:	$-0.610

FY	2022
Ingresos:	$1.54M
Beneficio Bruto:	$1.45M (94.40 %)
EPS:	$-0.950

FY	2021
Ingresos:	$0.00
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.667

Financial Reports:

No articles found.

Fennec Pharmaceuticals

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Actualizaciones en tiempo real para Fennec Pharmaceuticals [FENC]

Upcoming Earnings Alert